ARINA KIM: Open Payments
NPI 1891491957 · LAKEWOOD, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,627 in 116 payments from 15 companies in 2025. Trend: 2023 $356 · 2024 $2,455 · 2025 $2,627
Food & beverage: $2,427Education: $200
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 25 | $699 |
| PFIZER INC. | 19 | $408 |
| ABBVIE INC. | 20 | $296 |
| Novartis Pharmaceuticals Corporation | 20 | $284 |
| GENZYME CORPORATION | 9 | $275 |
| Regeneron Healthcare Solutions, Inc. | 5 | $200 |
| UCB, Inc. | 4 | $192 |
| Galderma Laboratories, L.P. | 3 | $67 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $58 |
| Lilly USA, LLC | 2 | $37 |
Products named: TREMFYA, DUPIXENT, CIBINQO, SKYRIZI, Bimzelx, COSENTYX, RINVOQ, NEMLUVIO.
Industry payments across WA — which companies pay providers there.
